 | Up a level |
2022
Schoenlein, Martin, Wrage, Victoria, Ghandili, Susanne, Mellinghoff, Sibylle C., Brehm, Thomas Theo, Leypoldt, Lisa B., Utz, Nils, Schrader, Roland M., Alsdorf, Winfried, Boerschel, Niklas, Bussmann, Lara, Schoenrock, Martin, Perlick, Dorothea, Schoen, Gerhard, Verpoort, Karl, Luetgehetmann, Marc, zur Wiesch, Julian Schulze, Weisel, Katja C., Bokemeyer, Carsten, Schafhausen, Philippe and Sinn, Marianne (2022). Risk factors for poor humoral response to primary and booster SARS-CoV-2 vaccination in hematologic and oncological outpatients-COVIDOUT study. Cancer Cell, 40 (6). S. 581 - 584. CAMBRIDGE: CELL PRESS. ISSN 1878-3686
Weisel, Katja, Besemer, Britta, Haenel, Mathias, Lutz, Raphael, Mann, Christoph, Munder, Markus, Goerner, Martin, Reinhardt, Hans Christian, Nogai, Axel, Ko, Yon-Dschun, De Wit, Maike, Salwender, Hans, Scheid, Christoph, Graeven, Ullrich, Peceny, Rudolf, Staib, Peter, Dieing, Annette, Jauch, Anna, Zago, Manola, Benner, Axel, Tichy, Diana, Bokemeyer, Carsten, Goldschmidt, Hartmut and Leypoldt, Lisa B. (2022). Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone (Isa-KRd) in Patients with High-Risk Newly Diagnosed Multiple Myeloma: Planned Interim Analysis of the GMMG-Concept Trial. Blood, 140. S. 1836 - 1839. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020